Pages that link to "Q38282974"

The following pages link to Arginine deprivation in cancer therapy (Q38282974):

Displaying 22 items.

• Evolutionary Limitation and Opportunities for Developing tRNA Synthetase Inhibitors with 5-Binding-Mode Classification (Q26775728) (← links)
• Amino acid deprivation using enzymes as a targeted therapy for cancer and viral infections (Q30040775) (← links)
• Proliferation and motility of hepatocellular, pancreatic and gastric cancer cells grown in a medium without glucose and arginine, but with galactose and ornithine (Q33598120) (← links)
• The Combination of Arginine Deprivation and 5-Fluorouracil Improves Therapeutic Efficacy in Argininosuccinate Synthetase Negative Hepatocellular Carcinoma (Q33838601) (← links)
• Attacking the supply wagons to starve cancer cells to death (Q34516773) (← links)
• Human recombinant arginase enzyme reduces plasma arginine in mouse models of arginase deficiency (Q37223655) (← links)
• Targeting cancer metabolism by simultaneously disrupting parallel nutrient access pathways (Q37395800) (← links)
• Cisplatin-induced synthetic lethality to arginine-starvation therapy by transcriptional suppression of ASS1 is regulated by DEC1, HIF-1α, and c-Myc transcription network and is independent of ASS1 promoter DNA methylation. (Q37696195) (← links)
• Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression (Q38616121) (← links)
• Molecular basis and current strategies of therapeutic arginine depletion for cancer. (Q38749541) (← links)
• Arginine dependence of tumor cells: targeting a chink in cancer's armor (Q38816145) (← links)
• Cancer metabolism: a therapeutic perspective (Q38824435) (← links)
• Arginine Metabolism Revisited. (Q39033964) (← links)
• Chromatin remodeling system p300-HDAC2-Sin3A is involved in Arginine Starvation-Induced HIF-1α Degradation at the ASS1 promoter for ASS1 Derepression (Q41534994) (← links)
• PEGylated arginine deiminase can modulate tumor immune microenvironment by affecting immune checkpoint expression, decreasing regulatory T cell accumulation and inducing tumor T cell infiltration (Q41708842) (← links)
• TLR4/IFNγ pathways induce tumor regression via NOS II-dependent NO and ROS production in murine breast cancer models (Q42122613) (← links)
• Metabolomic profiling identifies distinct phenotypes for ASS1 positive and negative GBM. (Q49344856) (← links)
• Arginase 1 promotes retinal neurovascular protection from ischemia through suppression of macrophage inflammatory responses (Q58698678) (← links)
• TRAIL stabilization and cancer cell sensitization to its pro-apoptotic activity achieved through genetic fusion with arginine deiminase (Q60960591) (← links)
• Role of tumor and host autophagy in cancer metabolism (Q92500806) (← links)
• Integrated Non-targeted and Targeted Metabolomics Uncovers Amino Acid Markers of Oral Squamous Cell Carcinoma (Q94465294) (← links)
• Arginine deprivation: a potential therapeutic for cancer cell metastasis? A review (Q94544273) (← links)